Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Positron Imaging Associates appears to be a healthcare-related operating entity associated with Positron's molecular imaging business rather than a drug-development biotech company. Available public evidence links the name to Positron's PET and PET-CT imaging activities and related clinical support services for nuclear medicine providers. The broader Positron organization develops and commercializes cardiac-focused PET and PET-CT imaging systems used in cardiology, with expanding applications in oncology and neurology imaging. No evidence was found that Positron Imaging Associates itself develops therapeutics or maintains a conventional biopharma pipeline. The entity is best characterized as a commercial healthcare/imaging company tied to diagnostic imaging technology and services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Positron Imaging Associates.